ORVILLE MURRAY: Open Payments
NPI 1700344686 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,082 in 45 payments from 17 companies in 2025. Trend: 2023 $1,290 · 2024 $1,255 · 2025 $1,082
Food & beverage: $1,083
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 10 | $238 |
| Axsome Therapeutics, Inc. | 6 | $150 |
| Neurocrine BioSciences, Inc. | 4 | $107 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $104 |
| Vanda Pharmaceuticals Inc. | 3 | $90 |
| ABBVIE INC. | 3 | $68 |
| Janssen Pharmaceuticals, Inc | 2 | $48 |
| Lundbeck LLC | 2 | $45 |
| Supernus Pharmaceuticals, Inc. | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
Products named: Azstarys, Auvelity, INGREZZA, CAPLYTA, FANAPT, REXULTI, VRAYLAR, Qelbree.
Industry payments across FL — which companies pay providers there.
